New inhaled powder shows promise for Lung-Related high blood pressure

NCT ID NCT06129240

First seen Feb 14, 2026 · Last updated May 15, 2026 · Updated 17 times

Summary

This study tests the safety of an inhaled dry powder drug called LIQ861 (treprostinil) in 80 adults with pulmonary hypertension (high blood pressure in the lungs) linked to lung disease. Participants receive the drug through an inhaler, and researchers monitor for side effects. The goal is to see if this treatment is safe and tolerable for long-term disease control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Advent Health

    Orlando, Florida, 32803, United States

  • Arizona Pulmonary Specialists

    Phoenix, Arizona, 85012, United States

  • Houston Methodist

    Houston, Texas, 77030, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • NYU Langone Medical Center

    New York, New York, 10016, United States

  • National Jewish Health

    Denver, Colorado, 80206, United States

  • Summit Health

    Bend, Oregon, 97701, United States

  • Tampa General Hospital Center of Research Excellence

    Tampa, Florida, 33606, United States

  • The Medical Research Group, Inc.

    Fresno, California, 93720, United States

  • UC Davis

    Sacramento, California, 95817, United States

  • UCLA Westwood

    Los Angeles, California, 90095, United States

  • UCSF

    San Francisco, California, 94143, United States

  • University of Cincinnati Health

    Cincinnati, Ohio, 45219, United States

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

  • University of Rochester

    Rochester, New York, 14627, United States

  • University of Utah

    Salt Lake City, Utah, 84112, United States

  • Vincent Medical Group

    Indianapolis, Indiana, 46260, United States

Conditions

Explore the condition pages connected to this study.